• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.82% Nasdaq Up2.46%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    14.81 Up 0.47(3.28%) 3:59PM EDT
    |After Hours : 14.82 Up 0.01 (0.07%) 5:26PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 2,178   486   1,477   1,101  
    Cost of Revenue -   -   -   -  
    Gross Profit 2,178   486   1,477   1,101  
    Operating Expenses
    Research Development26,490  25,125  27,026  26,186  
    Selling General and Administrative8,184  6,089  6,249  5,004  
    Non Recurring -   -   -   -  
    Others254  253  253  253  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (32,750) (30,981) (32,051) (30,342)
    Income from Continuing Operations
    Total Other Income/Expenses Net391  807  229  2,261  
    Earnings Before Interest And Taxes(32,359)(30,174)(31,822)(28,081)
    Interest Expense -   -   -   -  
    Income Before Tax(32,359)(30,174)(31,822)(28,081)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(32,359)(30,174)(31,822)(28,081)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (32,359) (30,174) (31,822) (28,081)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (32,359) (30,174) (31,822) (28,081)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.